torsemide

Known as: Torasemidum, 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea, Torasemide 
An anilinopyridine sulfonylurea belonging to the class of loop diuretics. Torsemide has a prolonged duration of action compared to other loop… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
0102019802017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE To investigate the diuretic effects, tolerability, and adverse effects of furosemide and torsemide after short- and… (More)
Is this relevant?
2007
2007
OBJECTIVES This study sought to investigate whether torasemide inhibits the enzyme involved in the myocardial extracellular… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVES This individually randomized, open-label, parallel-group pilot study was designed to test the hypothesis that the… (More)
  • table 1
Is this relevant?
2002
2002
BACKGROUND Diuretics such as torasemide are commonly used to treat chronic heart failure (CHF). AIMS The objective of the… (More)
Is this relevant?
2001
2001
PURPOSE Because the bioavailability of oral furosemide is erratic and often incomplete, we tested the hypothesis that patients… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Cytochrome P450 2C9 (CYP2C9) catalysis the metabolism of important drugs such as phenytoin, S-warfarin, tolbutamide, losartan… (More)
Is this relevant?
1998
1998
Torsemide inhibited aldosterone secretion by adrenal cells from rats, cows, and guinea pigs stimulated in vitro by potassium… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND Studies on the role of loop diuretics in patients with acute renal failure (ARF) are largely retrospective, anecdotal… (More)
  • table 2
  • table 4
  • table 3
  • figure 1
Is this relevant?
1997
1997
Single nucleotide substitutions are known to result in a different amino acid at one of four sites in cytochrome P4502C9 (CYP2C9… (More)
Is this relevant?
1995
1995
The bioavailability, pharmacokinetics, and pharmacodynamics of torsemide (10 mg orally and intravenously) and furosemide (40 mg… (More)
Is this relevant?